172 related articles for article (PubMed ID: 37594632)
21. Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma.
Jeong JS; Cho KJ; Kim D; Lee YS; Song JS
Pathol Res Pract; 2021 Dec; 228():153678. PubMed ID: 34781210
[TBL] [Abstract][Full Text] [Related]
22. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a subset of tumor suppressor gene for copy number and epigenitic changes in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma carcinogenesis.
Mariano FV; Egal ES; Pramio D; Fidalgo F; Sara É; Costa AF; de Oliveira Gondak R; Coletta RD; de Almeida OP; Kowalski LP; Victorino Krepischi AC; Altemani A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):322-31. PubMed ID: 27544395
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome of patients with carcinoma ex pleomorphic adenoma of the parotid gland: a comparative study from a single tertiary center.
Lim CM; Hobson C; Kim S; Johnson JT
Head Neck; 2015 Apr; 37(4):543-7. PubMed ID: 24677516
[TBL] [Abstract][Full Text] [Related]
25. Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.
Mariano FV; Giovanetti K; Saccomani LF; Del Negro A; Kowalski LP; Krepischi AC; Altemani A
Braz J Otorhinolaryngol; 2016; 82(6):687-694. PubMed ID: 26971045
[TBL] [Abstract][Full Text] [Related]
26. Partial response to RC-48 as palliative treatment in a patient with locallocally advanced carcinoma ex pleomorphic adenoma harboring a HER2 mutation: a case report.
Yu W; Ding C; Li K
Oral Oncol; 2023 Nov; 146():106541. PubMed ID: 37595449
[TBL] [Abstract][Full Text] [Related]
27. Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland.
Nakajima Y; Kishimoto T; Nagai Y; Yamada M; Iida Y; Okamoto Y; Ishida Y; Nakatani Y; Ichinose M
Pathology; 2009; 41(7):634-9. PubMed ID: 19672785
[TBL] [Abstract][Full Text] [Related]
28. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma.
Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y
Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.
Di Palma S
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206
[TBL] [Abstract][Full Text] [Related]
30. Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.
Kadowaki S; Yatabe Y; Hirakawa H; Komori A; Kondoh C; Hasegawa Y; Muro K
Case Rep Oncol; 2013; 6(3):450-5. PubMed ID: 24163659
[TBL] [Abstract][Full Text] [Related]
31. The significance of tyrosine kinase receptor B and brain-derived neurotrophic factor expression in salivary duct carcinoma.
Kondo Y; Hirabayashi K; Carreras J; Tsukinoki K; Ota Y; Okami K; Nakamura N
Ann Diagn Pathol; 2021 Feb; 50():151673. PubMed ID: 33248386
[TBL] [Abstract][Full Text] [Related]
32. Salivary duct carcinoma ex pleomorphic adenoma: analysis of the findings in fine-needle aspiration cytology and histology.
Ersöz C; Cetik F; Aydin O; Cosar EF; Talas DU
Diagn Cytopathol; 1998 Sep; 19(3):201-4. PubMed ID: 9740996
[TBL] [Abstract][Full Text] [Related]
33. Salivary duct carcinoma ex pleomorphic adenoma of the palate: a case report.
Bourell LG; Chan KC; Hirsch DL
J Oral Maxillofac Surg; 2015 Feb; 73(2):370.e1-7. PubMed ID: 25579019
[TBL] [Abstract][Full Text] [Related]
34. Frankly Invasive Carcinoma Ex-intraductal Carcinoma: Expanding on an Emerging and Perplexing Concept in Salivary Gland Tumor Pathology.
McLean-Holden AC; Rooper LM; Lubin DJ; Magliocca KR; Manucha V; Sadow PM; Tobias J; Vargo RJ; Thompson LDR; Heidarian A; Weinreb I; Wenig B; Gagan J; Hernandez-Prera JC; Bishop JA
Head Neck Pathol; 2022 Sep; 16(3):657-669. PubMed ID: 34985683
[TBL] [Abstract][Full Text] [Related]
35. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Nishiyama K; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195
[TBL] [Abstract][Full Text] [Related]
36. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
Matsubayashi S; Yoshihara T
Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
[TBL] [Abstract][Full Text] [Related]
37. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
Kusafuka K; Kawasaki T; Maeda M; Yamanegi K; Baba S; Ito Y; Inagaki H; Nakajima T
Histopathology; 2017 Jan; 70(2):164-173. PubMed ID: 27079821
[TBL] [Abstract][Full Text] [Related]
38. Primary and Secondary/ Metastatic Salivary Duct Carcinoma Presenting within the Sinonasal Tract.
Agaimy A; Mueller SK; Bishop JA; Chiosea SI
Head Neck Pathol; 2021 Sep; 15(3):769-779. PubMed ID: 33428064
[TBL] [Abstract][Full Text] [Related]
39. Desmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma.
de Araújo VC; Furuse C; Cury PR; Altemani A; Alves VA; de Araújo NS
Head Neck Pathol; 2007 Dec; 1(2):112-7. PubMed ID: 20614261
[TBL] [Abstract][Full Text] [Related]
40. Myoepithelial Carcinoma Ex-Pleomorphic Adenoma: A Rare Pathology Misdiagnosed as Pleomorphic Adenoma; With a Novel TERT Promoter Mutation and High PD-L1 Expression.
Cormier C; Agarwal S
Head Neck Pathol; 2022 Mar; 16(1):322-330. PubMed ID: 34128136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
